Superoxide Dismutase as an Intervention for Radiation Therapy-Associated Toxicities: Review and Profile of Avasopasem Manganese as a Treatment Option for Radiation-Induced Mucositis

References

• GershmanR, GilbertDL, NyeSW, et al. Oxygen poisoning and X-irradiation: a mechanism in common. Science. 1954;119:623–626. doi:10.1126/science.119.3097.62313156638
   PubMed Web of Science ®Google Scholar
• AzzamEI, Jay-GerinJP, PainD, et al. Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett. 2012;327:48–60.22182453
   PubMed Web of Science ®Google Scholar
• Collins-UnderwoodJR, ZhaoW, SharpeJG, et al. NADPH oxidase mediates radiation-induced oxidative stress in rat brain microvascular endothelial cells. Free Radic Biol Med. 2008;45:929–938. doi:10.1016/j.freeradbiomed.2008.06.02418640264
   PubMed Web of Science ®Google Scholar
• LeiY, WangK, DengL, et al. Redox regulation of inflammation: old elements, a new story. Med Res Rev. 2015;35:306–340.25171147
   PubMed Web of Science ®Google Scholar
• McCordJM, FridovichI. Superoxide dismutase: an enzymatic function for erythrocuprein (hemocuprein). J Biol Chem. 1969;244:6049–6055. doi:10.1016/S0021-9258(18)63504-55389100
   PubMed Web of Science ®Google Scholar
• IghodaroOM, AkinloyeOA. First line defence antioxidants – superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): their fundamental role in the entire antioxidant defence grid. Alexandria J Med. 2018;54:287–293. doi:10.1016/j.ajme.2017.09.001
   Web of Science ®Google Scholar
• GriessB, TomE, DomannF, et al. Extracellular superoxide dismutase and its role in cancer. Free Rad Biol Med. 2017;112:464–479.28842347
   PubMed Web of Science ®Google Scholar
• LavelleF, MichelsonAM, DimitrijevicL, et al. Biological protection by superoxide dismutase. Biochem Biophys Res Comm. 1973;55:350–357. doi:10.1016/0006-291X(73)91094-24588214
   PubMed Web of Science ®Google Scholar
• PetkauA, ChelackWS, PleskachSD, et al. Radioprotection of mice by superoxide dismutase. Biochem Biophys Res Comm. 1975;65:886–893. doi:10.1016/S0006-291X(75)80468-21156422
   PubMed Web of Science ®Google Scholar
• PetkauA, ChelackWS, PleskachSD, et al. Protection of post-irradiated mice by superoxide dismutase. Int J Radiat Biol. 1976;29:297–299.
   Web of Science ®Google Scholar
• Marberger H, et al. Orgotein: a new anti-inflammatory metalloprotein drug: preliminary evaluation of clinical efficacy and safety in degenerative joint disease. Curr Ther Res Clin Exp. 1974;16:706–717.4210460
   PubMed Web of Science ®Google Scholar
• MarbergerH, BartschG, HuberW, et al. Orgotein: a new drug for the treatment of radiation cystitis. Curr Ther Res Clin Exp. 1975;18:466–475.810307
   PubMed Web of Science ®Google Scholar
• EdsmyrF, Menander-HuberKB. Orgotein efficacy in ameliorating side effects due to radiation therapy. Eur J Rheumatol Inflam. 1981;4:228–236.
   PubMed Web of Science ®Google Scholar
• EscribanoA, Garcia-GrandeA, MontanesP, et al. Aerosol orgotein (Ontosein) for the prevention of radiotherapy-induced adverse effects in head and neck cancer patients: a feasibility study. Neoplasma. 2002;49:201–208.12098008
   PubMed Web of Science ®Google Scholar
• EscoR, ValenciaJ, CoronelP, et al. Efficacy of Orgotein in prevention of late side effects of pelvic irradiation: a randomized study. Int J Radiat Biol Phys. 2004;60:10–1211. doi:10.1016/j.ijrobp.2004.04.038
   Web of Science ®Google Scholar
• NielsenOS, OvergaardJ, OvergaardM, et al. Orgotein in radiation treatment of bladder cancer. Acta Oncologica. 1987;26:101–105. doi:10.3109/028418687090917482955799
   PubMed Web of Science ®Google Scholar
• LeQT, KimHE, SchneiderCJ, et al. Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study. J Clin Oncol. 2011;29(20):2808–2814. doi:10.1200/JCO.2010.32.409521670453
   PubMed Web of Science ®Google Scholar
• DelanianS, BailletF, HuartJ, et al. Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: clinical trial. Radiother Oncol. 1994;32:12–20. doi:10.1016/0167-8140(94)90444-87938674
   PubMed Web of Science ®Google Scholar
• MaierP, VeldwijkMR, WenzF, et al. Radioprotective gene therapy. Exp Opin Biol Ther. 2011;11(9):1135–1151. doi:10.1517/14712598.2011.580271
   PubMed Web of Science ®Google Scholar
• BonettaR. Potential therapeutic application of MnSODs and SOD-mimetics. Chem. 2018;24:5032–5041. doi:10.1002/chem.201704561
   PubMed Web of Science ®Google Scholar
• InoueM, WatanabeN, UtsumiT, et al. Targeting SOD by gene and protein engineering and inhibition of free radical injury. Free Radic Res Comm. 1991;P1:391–399. doi:10.3109/10715769109145809
   Google Scholar
• GuoH, Seixas-SilvaJA, EpperlyMW, et al. Prevention of radiation-induced oral cavity mucositis by plasmid/liposome delivery of the human manganese superoxide dismutase (SOD2) transgene. Radiat Res. 2003;159:361–370. doi:10.1667/0033-7587(2003)159[0361:PORIOC]2.0.CO;212600239
   PubMed Web of Science ®Google Scholar
• EpperlyMW, WegnerR, KanaiAJ, et al. Effects of MnSOD-plasmid liposome gene therapy on antioxidant levels in irradiated murine oral cavity orthotopic tumors. Radiat Res. 2007;167:289–297. doi:10.1667/RR0761.117316075
   PubMed Web of Science ®Google Scholar
• TarhiniAA, BelaniCP, LuketichJD, et al. A phase 1 study of concurrent chemotherapy (paclitaxel and carboplatin) and thoracic radiotherapy with swallowed manganese superoxide dismutase plasmid liposome protection in patients with locally advanced stage III non-small-cell lung cancer. Human Gene Ther. 2011;22:336–342. doi:10.1089/hum.2010.07820873987
   PubMed Web of Science ®Google Scholar
• EpperlyMW, SikoraC, DefilippiS, et al. Plasmid/liposome transfer of the human manganese superoxide dismutase transgene prevents ionizing irradiation-induced apoptosis in human esophagus organ explant culture. Int J Cancer. 2000;90:128–137. doi:10.1002/1097-0215(20000620)90:3<128::AID-IJC2>3.0.CO;2-U10900424
   PubMed Web of Science ®Google Scholar
• StickleRL, EpperlyMW, KleinE, et al. Prevention of irradiation-induced esophagitis by plasmid/liposome delivery of the human manganese superoxide dismutase transgene. Radiat Oncol Investig. 1999;7(4):204–217. doi:10.1002/(SICI)1520-6823(1999)7:4<204::AID-ROI2>3.0.CO;2-S
   Google Scholar
• GuoHL, WolfeD, EpperlyMW, et al. Gene transfer of human manganese superoxide dismutase protects small intestinal villi from radiation injury. J Gastrointest Surg. 2003;7:229–236. doi:10.1016/S1091-255X(02)00186-512600447
   PubMed Web of Science ®Google Scholar
• SouthgateTD, SheardV, MilsomMD, et al. Radioprotective gene therapy through retroviral expression on manganese superoxide dismutase. J Gene Med. 2006;8:557–565. doi:10.1002/jgm.89016506247
   PubMed Web of Science ®Google Scholar
• YanS, BrownSL, KolozsvaryA, et al. Mitigation of radiation-induced skin injury by AAV2-mediated MnSOD gene therapy. J Gene Med. 2008;10:1012–1018. doi:10.1002/jgm.122618613255
   PubMed Web of Science ®Google Scholar
• PetkauA. Scientific basis for the clinical use of superoxide dismutase. Cancer Treat Rec. 1986.
   Web of Science ®Google Scholar
• SalveminiD, RileyDP, CuzzocreaS, et al. SOD mimetics are coming of age. Nat Rev Drug Dis. 2002;1:367–379. doi:10.1038/nrd796
   PubMed Web of Science ®Google Scholar
• RileyDP, SchallOF. Structure-activity studies and design of synthetic superoxide dismutase (SOD) mimetics as therapeutics. Adv Inorganic Chem. 2007;59:233–263.
   Web of Science ®Google Scholar
• RileyDR, WeissRH. Manganese macrocyclic ligand complexes as mimics of superoxide dismutase. J Am Chem Soc. 1994;116:387–388. doi:10.1021/ja00080a051
   Web of Science ®Google Scholar
• SalveminiD, WangZQ, ZweierJL, et al. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science. 1999;286:304–306. doi:10.1126/science.286.5438.30410514375
   PubMed Web of Science ®Google Scholar
• SalveminiD, MazzonE, DugoL, et al. Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403. Brit J Pharmacol. 2001;132:815–827. doi:10.1038/sj.bjp.070384111181422
   PubMed Web of Science ®Google Scholar
• MuscoliC, CuzzocreaS, RileyDP, et al. On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies. Brit J Pharmacol. 2003;140:445–460. doi:10.1038/sj.bjp.070543014522841
   PubMed Web of Science ®Google Scholar
• CuzzocreaS, MazzonE, DugoL, et al. Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis. Eur J Pharmacol. 2001;432:79–89. doi:10.1016/S0014-2999(01)01427-311734191
   PubMed Web of Science ®Google Scholar
• DiPaolaR, MazzonE, RotondoF, et al. Reduced development of experimental periodontitis by treatment with M40403, a superoxide dismutase mimetic. Eur J Pharmacol. 2005;516:151–157. doi:10.1016/j.ejphar.2005.04.03915921679
   PubMed Web of Science ®Google Scholar
• CuzzocreaS, MazzonE, Di PaolaR, et al. Synergistic interaction between methotrexate and a superoxide dismutase mimetic: pharmacologic and potential clinical significance. Arthritis Rheum. 2005;52:3755–3760. doi:10.1002/art.2148016320326
   PubMed Web of Science ®Google Scholar
• CuzzocreaS, MazzonE, PaolaRD, et al. Effects of combination of M40403 and dexamethasone therapy on joint disease in a rat model of collagen-induced arthritis. Arthritis Rheum. 2005;52:1929–1940. doi:10.1002/art.2104415934059
   PubMed Web of Science ®Google Scholar
• BowenJ, Al-DasooqiN, BossiP, et al. The pathogenesis of mucositis: updated perspectives and emerging targets. Support Care Cancer. 2019;27:4023–4033. doi:10.1007/s00520-019-04893-z31286231
   PubMed Web of Science ®Google Scholar
• SonisST. Animal models for mucosal toxicity. In: TeicherB, editor. Animal Models in Cancer Research. Totowa, NJ: Humana Press; 2002.
   Google Scholar
• MurphyCK, FeyEG, WatkinsBA, et al. Efficacy of superoxide dismutase mimetic M40403 in attenuating radiation-induced oral mucositis in hamsters. Clin Cancer Res. 2008;14:4292–4297. doi:10.1158/1078-0432.CCR-07-466918594012
   PubMed Web of Science ®Google Scholar
• ThompsonJS, ChuY, GlassJ, et al. The manganese superoxide dismutase mimetic, M40403, protects adult mice from lethal total body irradiation. Free Rad Res. 2010;44:529–540. doi:10.3109/10715761003649578
   PubMed Web of Science ®Google Scholar
• ColemanMC, OlivierAK, JacobusJA, et al. Superoxide mediates acute liver injury in irradiated mice lacking sirtuin 3. Antioxid Redox Signalling. 2014;20:1423–1435. doi:10.1089/ars.2012.5091
   PubMed Web of Science ®Google Scholar
• SishcBJ, PolsdoferE, BloomDA, et al. The radioprotector GC4419 ameliorates radiation induced lung fibrosis while enhancing the response of non-small cell lung cancer tumors to high dose per fraction radiation exposures. Int J Rad Oncol Biol Phys. 2019;105(1):E680. doi:10.1016/j.ijrobp.2019.06.1002
   Web of Science ®Google Scholar
• SishcBJ, SahaD, StoryMD, et al. Avasopasem manganese protects against radiation induced oral mucositis and enhances the response of squamous cell carcinoma of the head and neck to ionizing radiation and radioimmune therapy. Int J Radiat Oncol Biol Phys. 2020;108:S159. doi:10.1016/j.ijrobp.2020.07.921
   Web of Science ®Google Scholar
• MapuskarKA, FlippoKH, SchoenfeldJD, et al. Mitochondrial superoxide dismutase increases age-associated susceptibility of human dermal fibroblasts to radiation and chemotherapy. Cancer Res. 2017;77:5054–5067. doi:10.1158/0008-5472.CAN-17-010628765155
   PubMed Web of Science ®Google Scholar
• El-MahdyMA, AlzarieYA, HemannC, et al. The novel SOD mimetic GC4419 increases cancer cell killing with sensitization to ionizing radiation while protecting normal cells. Free Rad Biol Med. 2020;160:630–642. doi:10.1016/j.freeradbiomed.2020.07.03232739595
   PubMed Web of Science ®Google Scholar
• AndersonCM, SonisST, LeeCM, et al. Phase 1b/2a trial of superoxide dismutase mimetic GC4419 to reduce chemoradiotherapy-induced oral mucositis in patients with oral cavity or oropharyngeal carcinoma. Int J Radiol Oncol Biol Phys. 2018;100:427–435. doi:10.1016/j.ijrobp.2017.10.019
   PubMed Web of Science ®Google Scholar
• AndersonCM, LeeCM, SaundersDP, et al. Phase 2b, randomized, double-blind trial of GC4419 vs placebo to reduce severe oral mucositis in head and neck cancer patients receiving concurrent radiotherapy and cisplatin. J Clin Oncol. 2019;37:3256–3265. doi:10.1200/JCO.19.0150731618127
   PubMed Web of Science ®Google Scholar
• HoffbauerM, FinebergJ, StattenfieldR, HolmlundJ. Cost of radiation-induced oral mucositis in head and neck cancer patients: an administrative claims analysis. JMCP. 2020;26(10–a Suppl):S31 (abs C48).
   Google Scholar
• SteinbachEJ, MongaV, FurqanM, et al. Effects of GC4419 (avasopasem manganese) on chronic kidney disease in head and neck cancer patients treated with radiation and cisplatin. J Clin Oncol. 2020;38(15_suppl):12071. doi:10.1200/JCO.2020.38.15_suppl.12071
   Web of Science ®Google Scholar
• MapuskarKA, WenH, HolandaDG, et al. Persistent increase in mitochondrial superoxide mediates cisplatin chronic kidney disease. Redox Biol. 2019;20:98–106. doi:10.1016/j.redox.2018.09.02030296702
   PubMed Web of Science ®Google Scholar
• AndersonCM, LeeCM, SaundersD, et al. Tumor outcomes of Phase IIb, randomized, double-blind trial of GC-4419 versus placebo to reduce severe oral mucositis due to concurrent radiotherapy and cisplatin for head and neck cancer. Int J Radiat Oncol Biol Phys. 2020;106:1221–1222. doi:10.1016/j.ijrobp.2020.02.004
   Web of Science ®Google Scholar
• AndersonCM, LeeCM, SaundersD, et al. 2-year outcomes of Phase IIb, randomized, double-blind trial of GC-4419 versus placebo to reduce severe oral mucositis due to concurrent radiotherapy and cisplatin for head and neck cancer. Int J Radiat Oncol Biol Phys. 2020;108:3836. doi:10.1016/j.ijrobp.2020.07.260
   Web of Science ®Google Scholar
• AshcraftKA, BossMK, TovmasyanA, et al. A novel manganese-porphyrin superoxide dismutase-mimetic widens the therapeutic margin in a pre-clinical head and neck cancer model. Int J Radiat Biol Phys. 2015;93:892–900. doi:10.1016/j.ijrobp.2015.07.2283
   Web of Science ®Google Scholar
• MapuskarKA, AndersonCM, SpitzDR, et al. Utilizing superoxide dismutase mimetics to enhance radiation therapy response while protecting normal tissues. Semin Radiat Oncol. 2019;29:72–80. doi:10.1016/j.semradonc.2018.10.00530573187
   PubMed Web of Science ®Google Scholar